MAP2K1 and glioblastoma: Conversely, TCTA and KIRC had low MEK1 mutation frequencies; and GBM, LGG, SARC, testicular germ cell tumor (TGCT), PRAD, PAAD and KIPR had almost no MEK1 mutation frequencies (Fig. 2A).